EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Quantitative Microbial Cell-Free DNA Sequencing From Plasma: A Potential Biomarker for the Diagnosis of Staphylococcal Infection of Cardiac Implantable Electronic Devices

Adolf W Karchmer iD, N Jenifer Kaufman iD, Sarah Y Park, Ronuk M Modi, Ahmed Abdul-Azim iD, Polly van den Berg, Jason D Matos, Daniel B Kramer iD, Peter J Zimetbaum

Clinical Infectious Diseases · 06.11.2025 · 81 (4) · 748-755

DOI: 10.1093/cid/ciaf113 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 11.03.2025. Verfasst von Adolf W Karchmer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Staphylococcal Infections, Cell-Free Nucleic Acids, Staphylococcus aureus, DNA, Bacterial. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: from Karius, Inc (to A. W. K.).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Staphylococcus aureus bacteremia in patients with cardiac implantable electronic devices (CIEDs) is often associated with infective endocarditis (CIED-IE). The CIED-IE diagnosis is syndromic. Diagnostic uncertainty is common. Frequently, these patients are classified as having possible CIED-IE, resulting in guideline-noncompliant treatment and heterogeneous outcomes. Improved outcomes require accurate diagnoses. In these patients, we evaluated whether metagenomic sequencing of microbial cell-free DNA (mcfDNA) in serial plasma specimens could improve diagnostic precision.

Methods

We studied 16 patients with staphylococcal bacteremia who were classified with definite or possible CIED-IE and recommended for device removal, if there was a positive blood culture within 7 days and no concurrent deep infection. Plasma specimens obtained at consent, before extraction, and during 96 hours after extraction underwent metagenomic sequencing and quantification of staphylococcal mcfDNA.

Results

In 10 of 11 patients with definite CIED-IE, mcfDNA persisted during antibiotic therapy for prolonged durations (median, 11 days [interquartile range {IQR}, 7.5–15 days]). In these cases, mcfDNA concentration in plasma obtained early after lead extraction increased significantly and thereafter decreased rapidly. In 5 cases of possible CIED-IE, mcfDNA was undetectable after 6 days (IQR, 5.5–7.5 days) of antibiotic therapy and remained undetectable after CIED extraction. These mcfDNA patterns differ significantly (P = .001), suggesting 2 distinct patient populations: 1 with definite CIED-IE and 1 without lead infection.

Conclusions

If confirmed, these mcfDNA patterns can serve as biomarkers, together with clinical features, to improve precision in diagnosing or rejecting S. aureus CIED-IE. Strategically timed mcfDNA testing before and after CIED extraction may aid in planning therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Staphylococcal InfectionsCell-Free Nucleic AcidsStaphylococcus aureusDNA, BacterialDefibrillators, ImplantableProsthesis-Related InfectionsBacteremiaEndocarditis, BacterialPacemaker, ArtificialHumansMaleFemaleAgedMiddle AgedBiomarkersAged, 80 and overSequence Analysis, DNAMetagenomicsAnti-Bacterial Agents

Stichwörter der Autor:innen

CIED infectioncardiac implantable electronic devicesinfective endocarditisplasma microbial cell-free DNA

Substanzen

Cell-Free Nucleic AcidsBiomarkersDNA, BacterialAnti-Bacterial Agents

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Medical Affairs, Karius, Inc, Redwood City, California, USA.
  • Division of Infectious Diseases, Department of Medicine, Robert Wood Johnson University Hospital, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.
  • Infectious Diseases, Pennsylvania Hospital, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.

ORCID-Profile: Adolf W Karchmer, N Jenifer Kaufman, Ahmed Abdul-Azim, Daniel B Kramer

Förderung

  • from Karius, Inc (to A. W. K.)

Zitieren

APA

Karchmer, A. W., Kaufman, N. J., Park, S. Y., Modi, R. M., Abdul-Azim, A., van den Berg, P., Matos, J. D., Kramer, D. B., & Zimetbaum, P. J. (2025). Quantitative Microbial Cell-Free DNA Sequencing From Plasma: A Potential Biomarker for the Diagnosis of Staphylococcal Infection of Cardiac Implantable Electronic Devices. Clinical Infectious Diseases, 81(4), 748-755. https://doi.org/10.1093/cid/ciaf113

Vancouver

Karchmer AW, Kaufman NJ, Park SY, Modi RM, Abdul-Azim A, van den Berg P, et al. Quantitative Microbial Cell-Free DNA Sequencing From Plasma: A Potential Biomarker for the Diagnosis of Staphylococcal Infection of Cardiac Implantable Electronic Devices. Clinical Infectious Diseases. 2025;81(4):748-755. doi:10.1093/cid/ciaf113

BibTeX
@article{Karchmer2025,
  author = {Karchmer, Adolf W and Kaufman, N Jenifer and Park, Sarah Y and Modi, Ronuk M and Abdul-Azim, Ahmed and van den Berg, Polly and Matos, Jason D and Kramer, Daniel B and Zimetbaum, Peter J},
  title = {Quantitative Microbial Cell-Free DNA Sequencing From Plasma: A Potential Biomarker for the Diagnosis of Staphylococcal Infection of Cardiac Implantable Electronic Devices},
  journal = {Clinical Infectious Diseases},
  year = {2025},
  volume = {81},
  number = {4},
  pages = {748--755},
  doi = {10.1093/cid/ciaf113}
}
Kostenlos starten →